Skip to main content
. 2018 Jan 1;32(1):31–37. doi: 10.1089/apc.2017.0196

Table 1.

Comparison of Youth Demographics Based on Mode of Disclosure

  Total, n = 280 Purposefully told, n = 57 (20%) Figured out on own, n = 223 (80%) p
Age at time of survey, median [IQR] 16.3 [14.7–18.6] 15.9 [14.5–18.3] 16.4 [14.7–18.6] 0.55
Age at disclosure, n = 216, median [IQR] 12.0 [10.2–13.8] 12.3 [9.6–13.7] 12.0 [10.3–13.8] 0.65
Gender (female), n (%) 155 (55.4) 29 (50.9) 126 (56.5) 0.45
Living status of biological parents, n (%)
 Both parents living 68 (24.3) 14 (24.6) 54 (24.2) 0.57
 One parent deceased 128 (45.7) 29 (50.9) 99 (44.4)
 Both parents deceased 84 (30.0) 14 (24.6) 70 (31.4)
Caregivers, n (%)
 Parent 125 (44.6) 25 (43.9) 100 (44.8) 0.89
 Aunt/uncle 71 (25.4) 13 (22.8) 58 (26.0)
 Grandparent 60 (21.4) 13 (22.8) 47 (21.1)
 Sibling 13 (4.6) 4 (7.0) 9 (4.0)
 Unknown 11 (3.9) 2 (3.5) 9 (4.0)
Tribe, n = 279, n (%)
 Chaga 183 (65.6) 35 (61.4) 148 (66.4) 0.57
 Pare 28 (10) 9 (15.8) 19 (8.5)
 Sukuma 5 (1.8) 1 (1.8) 4 (1.8)
 Other 63 (22.5) 12 (21.0) 51 (22.9)
Attending school, n (%) 213 (76.1) 47 (82.5) 166 (74.4) 0.21
Clinic site, n (%)
 KCMC 182 (65.0) 54 (94.7) 128 (57.4) <0.001
 Mawenzi 98 (35.0) 3 (5.3) 95 (42.6)
Antiretroviral therapy, n (%)
 None 20 (7.1) 7 (12.3) 13 (5.8) 0.153
 NNRTI-based 191 (68.2) 34 (57.9) 157 (70.0)
 PI-based 69 (24.6) 16 (29.8) 53 (24.2)

Count (%) reported unless otherwise stated.

IQR, interquartile range; KCMC, Kilimanjaro Christian Medical Center; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.